Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00406549 · ClinicalTrials.gov registry record
Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus
A clinical trial, sponsored by Solventum US.
- Completed
- Registry status
- 2,000
- Enrollment target
NCT00406549: Completed study, sponsored by Solventum US.
NCT00406549 is a clinical trial that has completed, run by Solventum US. The registered enrollment target is 2,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00406549 has completed, sponsored by Solventum US.
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
To establish the clinical test performance characteristics of sensitivity, specificity and predictive values for direct detection of nasal Staphylococcus aureus colonization against clinical microbiology laboratory culture methods.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2006-12 |
| Est. Completion | 2007-03 |
What the finished NCT00406549 record still lists
NCT00406549 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00406549 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00406549 about?
NCT00406549 is a clinical study titled "Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus". To establish the clinical test performance characteristics of sensitivity, specificity and predictive values for direct detection of nasal Staphylococcus aureus colonization against clinical microbiology laboratory culture methods.
What is the current status of trial NCT00406549?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2006-12. Estimated completion is 2007-03.
Who is sponsoring clinical trial NCT00406549?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia